SCHEMBL24015590

SCHEMBL24015590

CS(=O)(=O)N1CCC[C@@H]1c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNB2 P17787 1/20 0.58
▸ CHRNB4 P30926 1/20 0.58
▸ CHRNA3 P32297 1/20 0.58
▸ CHRNA7 P36544 1/20 0.58
▸ CHRNA4 P43681 1/20 0.58
▸ PSEN1 P49768 1/20 0.56
▸ PSEN2 P49810 1/20 0.56
▸ APH1B Q8WW43 1/20 0.56
▸ NCSTN Q92542 1/20 0.56
▸ APH1A Q96BI3 1/20 0.56
▸ PSENEN Q9NZ42 1/20 0.56
▸ TRPA1 O75762 2/20 0.50
▸ RIPK1 Q13546 1/20 0.50
▸ CYP3A4 P08684 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ ACLY P53396 1/20 0.48
▸ HCRTR2 O43614 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24015576 1.00 CHRNB2 (0.58) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL24015592 1.00 CHRNB2 (0.58) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL12536836 0.84 PSEN1 (0.46) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL7563410 0.84 PSEN1 (0.55) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL25587628 0.83 RIPK1 (0.52) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL25587630 0.83 RIPK1 (0.52) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL25587656 0.83 RIPK1 (0.52) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL6180588 0.83 PSEN1 (0.74) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL6180584 0.83 PSEN1 (0.74) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL15300976 0.83 TRPA1 (0.51) CHRNA7PSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230278958-A1 TRICYCLIC HETEROCYCLES MERCK PATENT GMBH (DE) 2023-09-07 — — US disclosed
WO-2023072974-A1 TRICYCLIC HETEROCYCLES MERCK PATENT GMBH (DE) 2023-05-04 — — WO disclosed
WO-2021224291-A1 TRICYCLIC HETEROCYCLES USEFUL AS TEAD BINDERS MERCK PATENT GMBH (DE) 2021-11-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230278958-A1 TRICYCLIC HETEROCYCLES YAP1, TERF2IP, TEAD1 CHRNB2 4703/4885CHRNB4 4794/4885CHRNA3 4687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback